Mounjaro and Zepbound account for roughly $36.5 billion of Eli Lillys ~$65.2 billion in 2025 revenue
GLP-1 Weight Loss Injections at En Vogue IV Therapy and Wellness Struggling to lose weightand keep it off
Semaglutide and high-dose Liraglutide are prescribed to manage obesity in overweight patients
If youre using semaglutide, youre more likely to experience gastrointestinal symptomsincluding but not limited to diarrhea during or shortly after arriving at the target dose
43,44 Given these neutral-to-concerning results, there is currently no evidence to support initiating GLP-1RAs for the primary treatment of HFrEF
With these official approvals and guideline recommendations, pharmaceutical companies are now able to conduct legitimate direct-to-consumer (DTC) education and outreach campaigns, accelerating the expansion of public awareness, acceptance and adoption of GLP-1 treatments in China